302536
Assistive Technology Needs and Difficulties in Activities of Daily Living among Children with Developmental Disabilities in the United States
The final analytic sample of children with DD was N=15,576. 98% of their parents reported that their AT needs were met. The gender distribution was 67.7% and 32.3 % for male and female respectively. The race/ethnicity distribution was predominantly white at 62.3%. Both Hispanic and Non-Hispanic black groups comprise of nearly 15% of the population. 96.9% of children with health insurance has their AT needs met. 93.4% of children whose AT needs are met reported difficulties in one or more ADL. The findings present positive news that the majority of children with DD in US have their AT needs met. This suggests that the provisions and continued implementation of federal legislations such as the Assistive Technology Act and the Individuals with Disabilities Education Act have supported the access to AT for children with DD.
Learning Areas:
EpidemiologyPublic health or related public policy
Learning Objectives:
Describe the sociodemographic distribution of children with developmental disabilities and their assistive technology needs
Analyze the association between assistive technology needs and functional status of children with DD in US
Discuss how the study finding reflect on the implementation of federal legislation related to assistive technology access and services
Keyword(s): Children With Special Needs, Technology
Qualified on the content I am responsible for because: Sue is currently a Senior Advisor at the Health Resources and Services Administration (HRSA) and previously the extramural research program officer with grant portfolio on autism and other related developmental disabilities. Prior to HRSA, Sue has worked on research, education, and dissemination initiatives in public health and disabilities at the national and state level. Sue was formerly the rehabilitation engineer for Massachusetts and West Virginia.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.